§ Federal grant opportunity · HT942526OCRPPA
DoW, Ovarian Cancer, Pilot Award
Christopher Meinberg Grantor is accepting applications for DoW, Ovarian Cancer, Pilot Award. The deadline is October 1, 2026 and the published award range is Award amount not published.
Key facts
- Funder
- Christopher Meinberg Grantor
- Application deadline
- October 1, 2026
- Award range
- Award amount not published
- Eligibility
- Eligibility criteria are published in the funding opportunity announcement.
- Geography
- United States
- Focus areas
- Research
- Opportunity number
- HT942526OCRPPA
Program overview
Summary: The Ovarian Cancer Pilot Award supports research that expands or modifies current thinking about and/or approaches in ovarian cancer, exploring innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward. Distinctive Features: Innovation is key. Research projects that demonstrate exceptional scientific merit but lack innovation do not meet the intent of the mechanism. Preliminary data are not required but are allowed for this mechanism. This mechanism includes a blinded pre-application component. Pre-applications to this funding opportunity will undergo a blinded pre-application screening. While preparing your pre-application, do not include any material that may identify the PI, a collaborator, or the organization of the PI or collaborator.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Christopher Meinberg Grantor.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before October 1, 2026, allowing time for registration and validation.
Related grant opportunities
- Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical Trial Optional)
- Sheep Production and Marketing Grant Program FY 2026
- Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P50 Clinical Trial Optional)
- Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
- Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.